Addition of histone deacetylase inhibitors in combination therapy
- PMID: 17513801
- DOI: 10.1200/JCO.2006.09.8293
Addition of histone deacetylase inhibitors in combination therapy
Comment on
-
Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study.J Clin Oncol. 2007 May 20;25(15):1979-85. doi: 10.1200/JCO.2006.08.6165. J Clin Oncol. 2007. PMID: 17513804 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
